/BAYRY
Bayer AG
BAYRY • OTCBAYRY • OTC • Healthcare
$10.99-1.96%-0.22
$10.99-1.96%(-0.22)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
70Bullish
Risk
83Low Risk
Momentum
58Neutral
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
59.2%▲4.8pp
Revenue after COGS
Operating
15.3%▲8.1pp
After operating expenses
Net
-7.9%▼2.5pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
-10.4
Price vs earnings
EV/EBITDA
6.3
Enterprise value
FCF Yield
5.5%
Cash generation
Earnings Yield
-9.6%
Inverse of P/E
Capital Efficiency
-1
GoAI Quality ScorePoor
ROEReturn on Equity
-13.4%Weak
ROAReturn on Assets
-3.1%Weak
ROICReturn on Invested Capital
8.0%Fair
Financial Health
Current RatioWeak
1.00
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
2.91x
Debt repayment capacity (<3x)
Income QualityWeak
-1.26
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $43.78B | $46.61B | $47.64B | $50.74B | $44.08B |
| Gross Profit | $25.92B | $25.34B | $27.89B | $30.87B | $27.27B |
| Gross Margin | 59.2% | 54.4% | 58.5% | 60.8% | 61.9% |
| Operating Income | $6.68B | $3.33B | -$150.00M | $6.26B | $6.97B |
| Net Income | -$3.48B | -$2.55B | -$2.94B | $4.15B | $1.00B |
| Net Margin | -7.9% | -5.5% | -6.2% | 8.2% | 2.3% |
| EPS | -$0.88 | -$0.65 | -$0.75 | $1.06 | $0.26 |
Rating Distribution
Strong Buy
0
0%
Buy
1
33%
Hold
2
67%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Citigroup▼ Downgrade
Buy→Neutral
2020-10-01Citigroup▼ Downgrade
Buy→Neutral
2020-09-30Jefferies▼ Downgrade
Buy→Hold
2018-08-15Jefferies▼ Downgrade
Buy→Hold
2018-08-14Citigroup▲ Upgrade
Neutral→Buy
2016-08-25Citigroup▲ Upgrade
Neutral→Buy
2016-08-24Morgan Stanley▲ Upgrade
Equal Weight→Overweight
2014-12-02Morgan Stanley▲ Upgrade
Equal Weight→Overweight
2014-12-01Earnings History & Surprises
BEAT RATE
65%
Last 17 quarters
AVG SURPRISE
+9.5%
EPS vs Estimate
BEATS / MISSES
11/4
2 met exactly
LATEST EPS
$0.18
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+58.6%
$0.18 vs $0.11
Q4 '25
+30.8%
$0.17 vs $0.13
Q3 '25
+40.0%
$0.35 vs $0.25
Q1 '25
$0.28 vs $0.28
Q4 '24
No data
Q4 '24
-58.8%
$0.07 vs $0.17
Q3 '24
$0.25 vs $0.25
Q2 '24
+68.9%
$0.77 vs $0.46
Q1 '24
+11.1%
$0.50 vs $0.45
Q4 '23
-64.3%
$0.10 vs $0.28
Q3 '23
-15.4%
$0.33 vs $0.39
Q2 '23
+43.6%
$0.79 vs $0.55
No investor questions available.
Latest News
No news available